Gangnam-gu Pharmaceutical Chapter announced to proceed with debate regarding the efficacy of Ursa, even if Daewoong absent

Published: 2014-03-17 15:20:29

Updated: 2014-03-17 15:20:29

On Mar 13, Gangnam-gu Pharmaceutical Chapter sent an official document to Daewoong Pharmaceutical related to a debate regarding the efficacy of Ursa (UDCA), and requested to attend the debate. It was told that Gangnam-gu Pharmaceutical Chapter plans to proceed with debate even if they absent.

It was conveyed that Daewoong decided not to attend the debate, because the subject of debate is not r...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.